Cargando…

Flow cytometric measurement of glutathione content of human cancer biopsies.

Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedley, D. W., Hallahan, A. R., Tripp, E. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971330/
https://www.ncbi.nlm.nih.gov/pubmed/2297492
_version_ 1782134886943948800
author Hedley, D. W.
Hallahan, A. R.
Tripp, E. H.
author_facet Hedley, D. W.
Hallahan, A. R.
Tripp, E. H.
author_sort Hedley, D. W.
collection PubMed
description Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2-2.0 fmol cell-1. Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCl and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with Coulter volume. By comparing tumour cell fluorescence to that of calibration beads, and assuming that the relationship with GSH content for EMT6 holds for other cells, a mean GSH content of 0.95 fmol cell-1 was derived for nine carcinomas, and 0.21 fmol cell-1 for five non-Hodgkin's lymphomas. Although this semi-quantitation needs further validation, the method used here is rapid, gives an indication of heterogeneity of tumour cell GSH content, and can be applied to fine needle biopsy samples. It therefore shows promise as a means for studying prospectively the relationship of GSH content to clinical drug and radiation sensitivity, and for monitoring the effects of agents such as buthionine sulphoximine which are intended to improve treatment results through tumour cell GSH depletion.
format Text
id pubmed-1971330
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19713302009-09-10 Flow cytometric measurement of glutathione content of human cancer biopsies. Hedley, D. W. Hallahan, A. R. Tripp, E. H. Br J Cancer Research Article Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2-2.0 fmol cell-1. Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCl and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with Coulter volume. By comparing tumour cell fluorescence to that of calibration beads, and assuming that the relationship with GSH content for EMT6 holds for other cells, a mean GSH content of 0.95 fmol cell-1 was derived for nine carcinomas, and 0.21 fmol cell-1 for five non-Hodgkin's lymphomas. Although this semi-quantitation needs further validation, the method used here is rapid, gives an indication of heterogeneity of tumour cell GSH content, and can be applied to fine needle biopsy samples. It therefore shows promise as a means for studying prospectively the relationship of GSH content to clinical drug and radiation sensitivity, and for monitoring the effects of agents such as buthionine sulphoximine which are intended to improve treatment results through tumour cell GSH depletion. Nature Publishing Group 1990-01 /pmc/articles/PMC1971330/ /pubmed/2297492 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Hedley, D. W.
Hallahan, A. R.
Tripp, E. H.
Flow cytometric measurement of glutathione content of human cancer biopsies.
title Flow cytometric measurement of glutathione content of human cancer biopsies.
title_full Flow cytometric measurement of glutathione content of human cancer biopsies.
title_fullStr Flow cytometric measurement of glutathione content of human cancer biopsies.
title_full_unstemmed Flow cytometric measurement of glutathione content of human cancer biopsies.
title_short Flow cytometric measurement of glutathione content of human cancer biopsies.
title_sort flow cytometric measurement of glutathione content of human cancer biopsies.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971330/
https://www.ncbi.nlm.nih.gov/pubmed/2297492
work_keys_str_mv AT hedleydw flowcytometricmeasurementofglutathionecontentofhumancancerbiopsies
AT hallahanar flowcytometricmeasurementofglutathionecontentofhumancancerbiopsies
AT trippeh flowcytometricmeasurementofglutathionecontentofhumancancerbiopsies